| 000 | 01683 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250514203730.0 | ||
| 264 | 0 | _c20050526 | |
| 008 | 200505s 0 0 eng d | ||
| 022 | _a0928-1231 | ||
| 024 | 7 |
_a10.1023/b:phar.0000035902.67235.5c _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFuchs, Sabine A | |
| 245 | 0 | 0 |
_aUse of angiotensin receptor antagonists in patients with ACE inhibitor induced angioedema. _h[electronic resource] |
| 260 |
_bPharmacy world & science : PWS _cAug 2004 |
||
| 300 |
_a191-2 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aAdverse Drug Reaction Reporting Systems |
| 650 | 0 | 4 |
_aAngioedema _xchemically induced |
| 650 | 0 | 4 | _aAngiotensin Receptor Antagonists |
| 650 | 0 | 4 |
_aAngiotensin-Converting Enzyme Inhibitors _xadverse effects |
| 650 | 0 | 4 |
_aBenzimidazoles _xadverse effects |
| 650 | 0 | 4 | _aBiphenyl Compounds |
| 650 | 0 | 4 | _aChronic Disease |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHeart Failure _xcomplications |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNetherlands _xepidemiology |
| 650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
| 650 | 0 | 4 |
_aReceptors, Angiotensin _xtherapeutic use |
| 650 | 0 | 4 |
_aTetrazoles _xadverse effects |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aWorld Health Organization |
| 700 | 1 | _aMeyboom, Ronald H B | |
| 700 | 1 | _avan Puijenbroek, Eugène P | |
| 700 | 1 | _aGuchelaar, Henk-Jan | |
| 773 | 0 |
_tPharmacy world & science : PWS _gvol. 26 _gno. 4 _gp. 191-2 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1023/b:phar.0000035902.67235.5c _zAvailable from publisher's website |
| 999 |
_c15139450 _d15139450 |
||